Leibo Xu
Guangzhou, 510080, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
The allosteric IDH1 inhibitor ivosidenib overcomes chemoresistance in intrahepatic cholangiocarcinoma models expressing wild-type IDH1.
Journal: The Journal of clinical investigation
Published: August 29, 2025
Development and validation of a novel prognostic model to predict 1-year post-transplant mortality for acute-on-chronic hepatitis B liver failure: a nationwide, multicentre, cohort study.
Journal: EClinicalMedicine
Published: March 20, 2025
Immune checkpoint inhibitor-related T-cell-mediated rejection increases the risk of perioperative graft loss after liver transplantation.
Journal: Chinese medical journal
Published: March 09, 2025
Tumor necrosis facilitates perihilar cholangiocarcinoma metastasis by ANGPTL6-augmented vessel permeability and tumor dissemination.
Journal: JHEP reports : innovation in hepatology
Published: February 14, 2025
Trem2/Tyrobp Signaling Protects Against Aortic Dissection and Rupture by Inhibiting Macrophage Activation in Mice.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: November 07, 2024
Short-term prognosis of recipients with pretransplant exposure to immune checkpoint inhibitors after liver transplantation for hepatocellular carcinoma: A retrospective cohort study.
Journal: Liver research (Beijing, China)
Published: July 31, 2024
Pretransplant immunotherapy increases acute rejection yet improves survival outcome of HCC patients with MVI post-liver transplantation.
Journal: Cancer immunology, immunotherapy : CII
Published: July 01, 2024
Pretransplant use of immune checkpoint inhibitors for hepatocellular carcinoma: A multicenter, retrospective cohort study.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: December 19, 2023
Oleic acid-PPARγ-FABP4 loop fuels cholangiocarcinoma colonization in lymph node metastases microenvironment.
Journal: Hepatology (Baltimore, Md.)
Published: August 06, 2023
Development of a clinical scoring model to predict the overall and relapse‑free survival of patients with hepatocellular carcinoma following a hepatectomy.
Journal: Molecular and clinical oncology
Published: June 20, 2023
Hepatitis B Virus Promotes Hepatocellular Carcinoma Progression Synergistically With Hepatic Stellate Cells via Facilitating the Expression and Secretion of ENPP2.
Journal: Frontiers in molecular biosciences
Published: July 23, 2021
EFTUD2 maintains the survival of tumor cells and promotes hepatocellular carcinoma progression via the activation of STAT3.
Journal: Cell death & disease
Published: April 26, 2020
Last Updated: 09/26/2026